RAPH — Raphael Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Raphael Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2008 December 31st | 2009 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.76 | -0.761 | -1.63 | -3.36 | -1.28 |
| Depreciation | |||||
| Non-Cash Items | 1.77 | 0.105 | — | 2.29 | 0.2 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | -0.174 | 0.206 | 0.309 | -0.119 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.994 | -0.831 | -1.42 | -0.759 | -1.2 |
| Capital Expenditures | — | -0.009 | — | -0.002 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.009 | — | -0.002 | 0 |
| Financing Cash Flow Items | — | — | 0.013 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.05 | 0.82 | 1.48 | 0.896 | 1.15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.052 | -0.019 | 0.058 | 0.135 | -0.058 |